Tarveda Therapeutics' Series B - III Round

Tarveda Therapeutics raised a round of funding on March 12, 2014.

Tarveda Therapeutics, fka Blend Therapeutics, is a biopharmaceutical company discovering and developing Pentarins as a new class of targeted anti-cancer medicines to advance the treatment of patients …

Articles about Tarveda Therapeutics' Series B - III Round: